Academic Staff

Home > People > Academic Staff

Professor David Shu-cheong HUI (許樹昌教授)

MBBS (UNSW), MD(UNSW), FRACP, FRCP (Lond, Glasg, Edin), FHKCP, FHKAM 

Associate Director (Clinical Liaison)

JC School of Public Health and Primary Care

 

Director, Stanley Ho Centre for Emerging Infections Diseases

Email: dschui@cuhk.edu.hk

 

Personal Website: http://www.cuhk.edu.hk/med/ceid/people__davidhui.htm

Division

Division of Infectious Diseases

Biography

Dr Hui graduated from the University of New South Wales in 1985. He then trained in Respiratory Medicine and Sleep Medicine in Sydney, Australia.


Dr Hui was heavily involved in the clinical management of patients with SARS at the Prince of Wales Hospital during the major outbreak in 2003. He served as a WHO advisor to review the clinical management of influenza A (H5N1)  during the early human outbreak in Vietnam in Feb 2004 and has since been a regular advisor to the WHO on the clinical management of severe acute respiratory infections. He has contributed to the WHO treatment guidelines including the clinical management of influenza A (H5N1) virus in 2007, clinical management of influenza A (H1N1) pandemic in 2009, and the Middle East Respiratory Syndrome (MERS) and the WHO training workshop in the clinical management of influenza A (H7N9) and other severe acute respiratory infections. He joined urgent WHO missions for investigation of outbreaks of MERS in Riyadh and South Korea in 2013 and 2015 respectively.

 

Dr Hui has published over 320 peer-reviewed journal articles and 24 book chapters since joining the CUHK in 1998.

Research Interest

Clinical management of emerging severe acute respiratory infections, the safety of respiratory therapy in the post SARS era, the efficacy of the medical ward airflow in preventing nosocomial infections, sleep disordered breathing, and common airway diseases.

 

Selected Publications 

  1. Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019 Dec;33(4):869-889.

  2. Hui DS, Ng SS. Recommended hospital preparations for future cases and outbreaks of novel influenza viruses. Expert Rev Respir Med. 2019 Oct 29:1-10. doi: 10.1080/17476348.2020.1683448. [Epub ahead of print]

  3. HUI DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, Gin T, Chan MT. Exhaled air dispersion during high flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019; Apr 11;53(4). pii: 1802339.

  4. Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018 Aug;18(8):e217-e227.

  5. 5)Hui DS, Lee N, Chan PK, Beigel JH. The role of adjuvant immunomodulatory agents for treatment of severe influenza. Antiviral Res. 2018 Feb;150:202-216.

  6. Chan MT, Chow BK, Lo T, Ko FW, Ng SS, Gin T, Hui DS. Exhaled air dispersion during bag-mask ventilation and sputum suctioning - Implications for infection control. Sci Rep. 2018 Jan 9;8(1):198.

  7. Xiao S, Li Y, Wong TW, Hui DS. Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong. PLoS One. 2017 Jul 20;12(7):e0181558.

  8. Lee N, Hui DS. Potential and challenges of serotherapy for severe influenza. Lancet Respir Med. 2017 Aug;5(8):e27.

  9. Hui DS, Ng SS, To KW, Ko FW, Ngai J, Chan KK, Yip WH, Chan TO, Yiu K, Tam WW. A randomized controlled trial of an ambulatory approach versus the hospital-based approach in managing suspected obstructive sleep apnea syndrome. Sci Rep. 2017 Apr 4;8:45901.

  10. Ko FW, Cheung NK, Rainer TH, Lum C, Wong I, Hui DS. Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial. Thorax. 2017 Feb;72(2):122-128.

More Publications

Please reload